Certolizumab Pegol is Effective for Chronic Plaque Psoriasis Across Patient Subgroups
Author Type(s)
Faculty
Document Type
Abstract
Publication Date
6-2018
Journal Title
Acta Dermato-Venereologica
Department
Dermatology
Recommended Citation
Reich, K., Blauvelt, A., Thaci, D., Leonardi, C., Poulin, Y., Burge, D., Peterson, L., Arendt, C., & Gottlieb, A. B. (2018). Certolizumab Pegol is Effective for Chronic Plaque Psoriasis Across Patient Subgroups. Acta Dermato-Venereologica, 98 (Suppl. 219), 27. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/351
COinS
